Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

1

Science community calls for transparency on AstraZeneca’s halted US COVID-19 vaccine trial

September 23, 2020 Research and Development AstraZeneca, COVID-19, Vaccine

The halting of AstraZeneca’s COVID-19 vaccine trial around the world was cause for much initial concern over the eventual safety …
News
credit_-_reuters

Fujifilm’s Avigan reduces recovery time in non-severe COVID-19 patients

September 23, 2020 Research and Development, Sales and Marketing

Fujifilm has announced promising new Phase 3 findings demonstrating that its antiviral therapy Avigan (favipravir) had a statistically significant impact …
News
fda_21

FDA set to announce stricter criteria for COVID-19 vaccines to receive Emergency Use Authorization

September 23, 2020 Research and Development

The FDA is set to release new guidelines that would raise safety and efficacy requirements required for a COVID-19 vaccine …
News
flu_shot_advertising

Contracting flu and COVID-19 simultaneously increases the risk of death, new study shows

September 23, 2020 Research and Development coronavirus vaccine, flu vaccine, vaccines

Public Health England has warned that catching seasonal flu and coronavirus at the same time could almost double the risk …
News
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

September 23, 2020 Research and Development COVID-19, coronavirus

The coronavirus news this week largely focuses on clinical trial results, with Pfizer saying that participants in a late-stage trial …
News
merckincweb

Positive five-year Keytruda survival data revealed at ESMO in metastatic, PD-L1+ non-small cell lung cancer

September 22, 2020 Manufacturing and Production, Research and Development ESMO 2020, MSD, keytruda, pharma

MSD took the opportunity at the European Society for Medical Oncology (ESMO) Virtual Congress 2020 to unveil new Phase 3 …
News
shutterstock_38078521

New Lenvima/Keytruda combo data in a range of cancers presented at ESMO 2020

September 21, 2020 Research and Development, Sales and Marketing Cancer, ESMO2020, Eisai, Lenvima, MSD, keytruda

New data from two studies investigating the combination of Eisai’s multiple receptor tyrosine kinase inhibitor Lenvima (lenvatinib) and MSD’s blockbuster …
News
shutterstock_159488225

Piqray and Faslodex combo extends survival in HR+/HER2-, PIK3CA+ advanced breast cancer at ESMO 2020

September 21, 2020 Research and Development, Sales and Marketing Cancer, ESMO 2020, Novartis, pharma

New data has been unveiled for the combination of Novartis’ Piqray (alpelisib) with AstraZeneca’s Faslodex (fulvestrant) in the treatment of …
News
libtayo

Promising Phase 2 data for Sanofi and Regeneron’s PD-1 inhibitor Libtayo in locally advanced basal cell carcinoma

September 18, 2020 Medical Communications, Research and Development Cancer, ESMO 2020, Libtayo, Regeneron, Sanofi, pharma

Promising Phase 2 data has been released at the European Society for Medical Oncology (ESMO) Virtual Congress 2020 for Sanofi …
News
256px-mikhail_murashko_2020-01-29

One in seven Russian COVID-19 vaccine recipients display side-effects, says Health Minister

September 18, 2020 Medical Communications, Research and Development COVID-19, Russia, Sputnik V, Vaccine

Around one in seven patients who have received Russia’s vaccine against COVID-19 have displayed side-effects in clinical studies, according to …
News
novartis_outside_1

Novartis’ Tafinlar/Mekinist combo improves five-year relapse-free survival in new Phase 3 data

September 17, 2020 Research and Development Novartis, Tafinlar, mekinist, melanoma

Novartis has unveiled promising new Phase 3 data for its combination of Tafinlar (dabrafenib) with Mekinist (trametinib) in the treatment …
News
800px-vaccine_image_1

Oxford University says participant illness that halted its COVID-19 trial may not be linked to the vaccine

September 17, 2020 Research and Development coronavirus vaccines, vaccines

The illness of one of the participants in the Oxford-AstraZeneca COVID-19 vaccine trial may not have been caused by the …
News
donald_trump_29496131773

US sets out plans to distribute free coronavirus vaccines

September 17, 2020 Research and Development

The Trump administration has laid out its strategy to distribute COVID-19 vaccines for free across the US.  The Department of …
News
alex_azar_-_pete_marovich-getty_images

HHS Secretary Alex Azar accused of overruling FDA on COVID-19 test quality reviews

September 16, 2020 Research and Development COVID-19, FDA, US, USA

Allegations have emerged accusing US Health and Human Services Secretary Alex Azar of overruling the FDA over the review of …
News
gettyimages-1206570416

India signs deal for 100m doses of Russia’s Sputnik V COVID-19 vaccine

September 16, 2020 Manufacturing and Production, Research and Development COVID-19, India, Russia, Vaccine

Russia has signed a deal with an Indian pharma firm to test and deliver 100 million doses of its controversial …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026